Immunobiosensor determination of β-agonists in urine using integrated immunofiltration clean-up

International Journal of Food Science and Technology

Volumn 39, Issue 8, 2004, Pages 891-898

  Johansson, Marie Annette ^a   Hellenäs, Karl Erik ^a  

^a NATIONAL FOOD ADMINISTRATION   (Sweden)

Author keywords

Clenbuterol; Residue analysis; Salbutamol; Surface plasmon resonance biosensor

Indexed keywords

CLENBUTEROL; IMMUNOBIOSENSORS; RESIDUE ANALYSIS; SALBUTAMOL; SURFACE PLASMON RESONANCE BIOSENSORS;

ANTIBODIES; BIOSENSORS; FILTERS (FOR FLUIDS); IMMUNOLOGY; SCREENING; SURFACE PLASMON RESONANCE; ULTRAFILTRATION;

BODY FLUIDS;

BOVINAE; VISCUM; VISCUM ALBUM;

EID: 8344254358     PISSN: 09505423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2621.2004.00863.x     Document Type: Article

References (25)

1. Collins, S., O'Keeffe, M. & Smyth, M.R. (1994). Multiresidue analysis for beta-agonists in urine and liver samples using mixed phase columns with determination by radioimmunoassay. Analyst, 119, 2671-2674.
2. Degand, G., Bernes-Duykaerts, A., Delahaut, P. & Maghuin-Rogister, G. (1993). Determination of β-agonists in urine by an enzyme immunoassay based on the use of an anti-salbutamol antiserum. Analytica Chimica Acta, 275, 241-247.
3. Elliott, C.T., McCaughey, W.J. & Shortt, H.D. (1993). Residues of the beta-agonist clenbuterol in tissues of medicated farm animals. Food Additives and Contaminants, 10, 231-244.
4. Elliott, C.T., Baxter, G.A., Hewitt, S.A. et al. (1998). Use of biosensors for rapid drug residue analysis without sample deconjugation or clean-up: a possible way forward. Analyst, 123, 2469-2473.
5. European Commission (1996). Council Directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of β-agonists, and repealing Directives 88/146/EEC and 88/299/EEC. Official Journal of the European Communities, L125, 3-9.
6. European Commission (2002). Commission Decision 2002/657/EC of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Official Journal of the European Communities, L221, 8-36.
7. European Commission (2004). Report for 2002 on the results of residue monitoring in food of animal origin in the Member States [WWW document]. URL http://europa.eu.int/comm/food/food/chemicalsafety/residues/control_en.htm, (in press).
8. van Ginkel, L.A., Stephany, R.W. & van Rossum, H.J. (1992). Development and validation of a multiresidue method for β-agonists in biological samples and animal feed. Journal of AOAC International, 75, 554-560.
9. Haasnoot, W., Cazemier, G., Stouten, P. & Kemmers-Voncken, A. (1996a). Immunochemical approaches to the analysis of β-agonistic drugs. In: Immunoassays for Residue Analysis - Food Safety (edited by R.C. Beier & L.H. Stanker). Pp. 60-73. American Chemical Society, Washington, DC.
10. Haasnoot, W., Streppel, L., Cazemier, G. et al. (1996b). Development of a tube enzyme immunoassay for 'on-site' screening of urine samples in the presence of beta-agonists. The Analyst, 121, 1111-1114.
11. Haasnoot, W., Kemmers-Voncken, A. & Samson, D. (2002). Immunofiltration as sample clean up for the immunochemical detection of β-agonists in urine. The Analyst, 127, 87-92.
12. Hahnau, S. & Jülicher, B. (1996). Evaluation of commercially available ELISA test kits for the detection of clenbuterol and other β-agonists. Food Additives and Contaminants, 13, 259-274.
13. Haughey, S.A., Baxter, G.A., Elliott, C.T., Persson, B., Jonson, C. & Bjurling, P. (2001). Determination of clenbuterol residues in bovine urine by optical immunobiosensor assay. The Journal of AOAC International, 84, 1025-1030.
14. Johansson, M.A. & Hellenäs, K-E. (2001). Sensor chip preparation and assay construction for immunobiosensor determination of beta-agonists and hormones. The Analyst, 126, 1721-1727.
15. Johansson, M.A. & Hellenäs, K-E. (2004a). Immunobiosensor analysis of clenbuterol in bovine hair. Food and Agricultural Immunology, (in press).
16. Johansson, M.A. & Hellenäs, K.-E. (2004b). Matrix effects in immunobiosensor determination of clenbuterol in urine and serum. Analyst, 129, 438-442.
17. Kuiper, H.A., Noordam, M.Y., van Dooren-Flipsen, M.M.H., Schilt, R. & Roos, A.H. (1998). Illegal use of beta-adrenergic agonists: European Community. Journal of Animal Science, 76, 195-207.
18. Maistro, S., Chiesa, E., Angeletti, R. & Brambilla, G. (1995). Beta blockers to prevent clenbuterol poisoning. Lancet, 346, 180.
19. Martinez-Navarro, J.F. (1990). Food poisoning related to consumption of illicit beta-agonist in liver. Lancet, 336, 1311.
20. Prezelj, A., Obreza, A. & Pecar, S. (2003). Abuse of clenbuterol and its detection. Current Medicinal Chemistry, 10, 281-290.
21. Pulce, C., Lamaison, D., Keck, G., Bostvironnois, C., Nicolas, J. & Descotes, J. (1991). Collective human food poisonings by clenbuterol residues in veal liver. Veterinary Human Toxicology, 33, 480-482.
22. Salleras, L., Dominguez, A., Mata, E., Taberner, J.L., Moro, I. & Salva, P. (1995). Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain. Public Health Reports, 110, 338-342.
23. Sterk, S.S., van Tricht, E.F., Stephany, R.W. & van Ginkel, L.A. (1998). Lyophilised samples of blank urine for the validation and quality control of residue analysis for growth promoting compounds. RIVM report 3890002047. RIVM, Bilthoven, the Netherlands.
24. Traynor, I.M., Crooks, S.R.H., Bowens, J. & Elliott, C.T. (2003). Detection of multi-β-agonist residues in liver matrix by use of a surface plasma resonance biosensor. Analytica Chimica Acta, 483, 187-191.
25. Yamamoto, I. & Iwata, K. (1982). Enzyme immunoassay for clenbuterol, an beta 2-adrenergic stimulant. Journal of Immunoassay, 3, 155-171.